9) Medical Diagnostics
Abstract
Investigate medical diagnostics that are agnostic against chemical and biological threats (including NTAs, pharmaceutical-based agents, and toxins) by advancing diagnostic innovations; investigating emerging technologies; ensuring medical diagnostics rapid adaptation to emerging threats; develop prototypes and tools that advance medical diagnostics towards FDA approval. This effort is being separated into four thrust areas starting in FY21: Battlefield Readiness, Chemical Diagnostics, Clinical Evaluation, and Emerging Threats.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2022
- Source ID
- 988bf5f0910a484061a8597c3728be64